Tumor infiltrating lymphocytes, or TILs, are often enriched in glioblastoma (GBM) with a mesenchymal gene expression signature and are strongly associated with mutations in NF1 and RB1 [75]. The gene discussed is NF1; the disease is glioblastoma.